$0.62
3.60%
Nasdaq, Dec 26, 09:00 pm CET
ISIN
US68373L2088
Symbol
OPGN
Sector
Industry

OpGen, Inc. Stock price

$0.64
-0.90 58.60% 1M
-1.89 74.80% 6M
-3.56 84.82% YTD
-3.78 85.58% 1Y
-221.36 99.71% 3Y
-261.36 99.76% 5Y
-484,999.36 100.00% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.02 2.92%
ISIN
US68373L2088
Symbol
OPGN
Sector
Industry

Key metrics

Market capitalization $6.42m
Enterprise Value $7.03m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.54
P/S ratio (TTM) P/S ratio 5.06
P/B ratio (TTM) P/B ratio 2.15
Revenue growth (TTM) Revenue growth -58.77%
Revenue (TTM) Revenue $1.27m
EBIT (operating result TTM) EBIT $-5.97m
Free Cash Flow (TTM) Free Cash Flow $-6.31m
Cash position $1.63m
EPS (TTM) EPS $-12.96
Short interest 1.79%
Show more

Is OpGen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

OpGen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast OpGen, Inc.:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast OpGen, Inc.:

Hold
100%

Financial data from OpGen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1.27 1.27
59% 59%
100%
- Direct Costs 1.30 1.30
55% 55%
102%
-0.03 -0.03
115% 115%
-2%
- Selling and Administrative Expenses 5.18 5.18
54% 54%
408%
- Research and Development Expense 0.38 0.38
94% 94%
30%
-5.60 -5.60
67% 67%
-441%
- Depreciation and Amortization 0.38 0.38
73% 73%
30%
EBIT (Operating Income) EBIT -5.97 -5.97
67% 67%
-470%
Net Profit -9.40 -9.40
64% 64%
-740%

In millions USD.

Don't miss a Thing! We will send you all news about OpGen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OpGen, Inc. Stock News

Neutral
InvestorPlace
4 months ago
OpGen (NASDAQ: OPGN ) just reported results for the second quarter of 2024. OpGen reported earnings per share of -$1.18.

Company Profile

OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

Head office United States
CEO Hon Tan
Founded 2001
Website www.opgen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today